Fresenius Raises €1.1 Billion for Stake in Dialysis Company
This article is for subscribers only.
Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as exchangeable bonds linked to the dialysis firm, as it looks to cut debt and reallocate capital.
The German group sold 10.6 million shares in Fresenius Medical Care to raise around €471 million, and about €600 million worth of three-year zero-coupon exchangeable bonds, Fresenius said in a statement on Tuesday.